The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice.
 
Serena Zheng
No Relationships to Disclose
 
Kanika Gupta
No Relationships to Disclose
 
Piyush Goyal
No Relationships to Disclose
 
Reiko Nakajima
No Relationships to Disclose
 
Laure Michaud
No Relationships to Disclose
 
Connie Lee Batlevi
Honoraria - Dava Oncology
Consulting or Advisory Role - Celgene; Gerson Lehrman Group; Juno Therapeutics; Kite, a Gilead company; Lifesci Capital; Lifesci Capital; Seagen
Research Funding - Bayer (Inst); Epizyme; Janssen Biotech; Novartis; Xynomic Pharma
 
Paul A. Hamlin
No Relationships to Disclose
 
Steven M. Horwitz
Consulting or Advisory Role - ADC Therapeutics; Affimed Therapeutics; Astex Pharmaceuticals; Celgene; Corvus Pharmaceuticals; Innate Pharma; Kura Oncology; Kyowa Hakko Kirin; Millennium; miRagen; Portola Pharmaceuticals; Seagen; Takeda; Verastem
Research Funding - ADC Therapeutics (Inst); Aileron Therapeutics (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Forty Seven (Inst); Kyowa Hakko Kirin (Inst); Seagen (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Verastem (Inst)
 
Anita Kumar
No Relationships to Disclose
 
Matthew J. Matasar
Stock and Other Ownership Interests - Merck
Honoraria - Bayer; Genentech; GlaxoSmithKline; Janssen; Pharmacyclics; Roche; Seagen
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Teva
Research Funding - Bayer; Genentech; GlaxoSmithKline; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Alison J. Moskowitz
No Relationships to Disclose
 
Craig H. Moskowitz
No Relationships to Disclose
 
Ariela Noy
Consulting or Advisory Role - MorphoSys
Speakers' Bureau - Prime Oncology
Research Funding - Pharmacyclics; Rafael Pharmaceuticals
Travel, Accommodations, Expenses - Janssen Oncology; Pharmacyclics
 
Maria Lia Palomba
Stock and Other Ownership Interests - Seres Therapeutics (I)
Honoraria - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Merck; Merck (I); Novartis (I); Pharmacyclics; Seres Therapeutics (I); Therakos (I)
Consulting or Advisory Role - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Kite, a Gilead company; Merck; Merck (I); Novartis; Novartis (I); Seres Therapeutics (I); Therakos (I)
Research Funding - Seres Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Intellectual Property Rights (I); Juno intellectual property rights (Inst)
 
David J. Straus
No Relationships to Disclose
 
Heiko Schöder
Consulting or Advisory Role - Aileron Therapeutics
 
Joachim Yahalom
No Relationships to Disclose
 
Andrew David Zelenetz
Stock and Other Ownership Interests - Adaptive Biotechnologies
Honoraria - Clinical Care Options; NCCN; Oncology Information Group; PER
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Cancer Support Community; Celgene; Dava Oncology; Genentech/Roche; Gilead Sciences; Janssen; Karyopharm Therapeutics; Medscape; MEI Pharma; MorphoSys; Novartis; Pfizer; Pharmacyclics; Prime Education; TRM Oncology; Vaniam Group; Verastem
Research Funding - BeiGene; Genentech/Roche; Gilead Sciences; MEI Pharma
 
Anas Younes
Honoraria - Abbvie; Curis; Epizyme; Janssen; Merck; Roche; Takeda
Consulting or Advisory Role - Bio-Path Holdings, Inc; Celgene; Epizyme; HCM; Roche; Xynomic Pharma
Research Funding - Bristol-Myers Squibb (Inst); Curis (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); Roche (Inst); Syndax (Inst)
 
Erel Joffe
Consulting or Advisory Role - AstraZeneca